Interleukin-1β promotes human metapneumovirus replication via activating the cGAS-STING pathway

Guojin Wu1, Yueyan Zhang1, Linlin Niu1

  • 1National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.

Virus Research
|March 2, 2024
PubMed
Abstract

Insights

Interleukin-1β (IL-1β) promotes human metapneumovirus (hMPV) replication by activating the cGAS-STING pathway. Targeting IL-1β offers a potential strategy to combat hMPV infections.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Human metapneumovirus (hMPV) is a common cause of acute lower respiratory tract infections.
  • Interleukin-1β (IL-1β) is implicated in viral replication, with elevated levels observed in hMPV-infected patients.
  • The precise mechanism of IL-1β's influence on hMPV replication is not fully understood.

Purpose of the Study:

  • To investigate the role of IL-1β in hMPV replication.
  • To elucidate the underlying molecular mechanism involving the cGAS-STING pathway.

Main Methods:

  • An hMPV infection model using 16HBE cells was established.
  • Quantitative real-time PCR and Western Blot were employed to measure IL-1β, cGAS, and STING expression.
  • IL-1β levels were modulated using siRNA and exogenous supplementation, and cGAS-STING pathway inhibitors were utilized.

Main Results:

  • hMPV infection led to time- and dose-dependent increases in IL-1β protein levels.
  • The mRNA and protein expression of cGAS and STING were significantly upregulated post-infection.
  • Reducing IL-1β levels decreased hMPV viral loads, while IL-1β supplementation enhanced viral replication.
  • Inhibition of the cGAS-STING pathway reduced hMPV replication.

Conclusions:

  • IL-1β promotes hMPV replication via the cGAS-STING pathway.
  • Targeting IL-1β presents a potential therapeutic strategy for controlling hMPV infections.